Detalhe da pesquisa
1.
Efficacy and safety of lurbinectedin and doxorubicin in relapsed small cell lung cancer. Results from an expansion cohort of a phase I study.
Invest New Drugs
; 39(5): 1275-1283, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33704620